Galapagos Announces Major Restructuring with Split into Two Publicly Traded Companies

In a significant strategic move, the biotechnology firm Galapagos has revealed its decision to split into two distinct publicly traded entities. This restructuring initiative aims to streamline operations and enhance focus on its core business areas. This news marks a pivotal moment for the company, which has sought to navigate challenges in the competitive biotech landscape.

Continue reading